# VOYXACT
> **BLA761434** · Biologics License Application · Sponsor: OTSUKA PHARM CO LTD · Approved 2025-11-25
## Drug
- **FDA Application Number:** BLA761434
- **Application type:** Biologics License Application
- **Brand name:** VOYXACT
- **Generic name:** SIBEPRENLIMAB
- **Active ingredients:** SIBEPRENLIMAB-SZSI
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** OTSUKA PHARM CO LTD
- **Manufacturer:** Otsuka America Pharmaceutical, Inc.
- **First approval:** 2025-11-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761434)
---
*MORVS · CC0 1.0*